transplant
wait
list
urinari
tract
infect
common
kidney
pancrea
transplant
candid
kidney
transplant
candid
also
risk
infect
nativ
kidney
occult
abscess
liver
transplant
candid
may
intraabdomin
infect
aspir
pneumonia
pneumonia
also
common
heart
lung
candid
popul
hospit
candid
risk
catheteror
devicerel
infect
associ
dialysi
access
devic
ventricular
assist
devic
vad
august
candid
heart
transplant
wait
list
unit
state
date
heart
transplant
procedur
perform
unit
state
thu
demand
donor
heart
far
exce
suppli
vad
develop
augment
circul
patient
endstag
heart
diseas
devic
approv
food
drug
administr
three
purpos
bridg
patient
heart
transplant
bridg
patient
recoveri
nativ
myocardi
function
provid
perman
support
patient
deem
suitabl
heart
transplant
candid
lifetim
destin
therapi
vad
support
right
left
ventricl
stabil
patient
condit
increas
cardiac
output
improv
perfus
vital
organ
restor
mobil
devic
typic
implant
median
sternotomi
incis
place
preperiton
intraabdomin
pocket
major
compon
vad
inflow
outflow
cannula
unidirect
valv
polyurethan
chamber
pulsatil
devic
pump
rotor
devic
connect
extern
power
sourc
drivelin
exit
abdomin
wall
fig
vad
contain
biomateri
unfortun
none
materi
biolog
inert
therefor
event
occur
hostimpl
interfac
trigger
aberr
immun
activ
patient
blood
come
contact
foreign
vad
surfac
cell
becom
activ
initi
defect
prolif
respons
subsequ
activationinduc
cell
death
result
patient
immun
system
impair
patient
may
suscept
infect
infect
common
complic
vad
therapi
vadrel
infect
may
delay
prevent
transplant
altogeth
major
caus
morbid
mortal
lifetim
therapi
patient
recent
intern
societi
heart
lungmechan
circulatori
support
devic
registri
data
indic
infect
occur
vad
patient
enrol
databas
patient
vad
infect
mortal
rate
devicerel
infect
rate
report
literatur
rang
potenti
infect
site
includ
surgic
site
compon
vad
drivelin
devic
pocket
pump
membran
drivelin
infect
common
howev
half
infect
involv
sever
devic
site
simultan
vad
infect
may
remain
local
becom
system
infect
spread
multipl
site
seriou
complic
bloodstream
infect
bacteremia
sepsi
endocard
ensu
devic
patient
mechanicalrel
factor
contribut
vad
infect
devicerel
factor
includ
exposur
percutan
drivelin
pathogen
vad
caviti
pocket
harbor
pathogen
microorgan
caus
blood
flow
pump
becom
turbul
turn
enabl
pathogen
adher
surfac
devic
patientrel
risk
factor
infect
includ
older
age
poor
nutrit
statu
indwel
cathet
prolong
intub
postop
bleed
blood
transfus
multiorgan
dysfunct
comorbid
diabet
mellitu
obes
prolong
hospit
vad
implant
surgic
reexplor
mechan
trauma
drivelin
exit
site
frequent
associ
lateonset
day
implant
infect
drivelin
trauma
occur
exampl
control
batteri
pack
drop
drivelin
snare
object
accid
result
shear
torsion
injuri
lead
infect
devicerel
infect
occur
time
howev
major
develop
week
month
implant
gramposit
pathogen
particularli
staphylococcu
speci
caus
infect
organ
abl
form
protect
biofilm
blunt
host
immun
respons
enabl
attach
grow
inanim
surfac
fungal
gramneg
bacilli
pseudomona
aeruginosa
enterobact
klebsiella
speci
caus
agent
particular
pathogen
associ
poorer
outcom
administr
broadspectrum
antibiot
often
lead
develop
fungal
infect
clinic
manifest
vadrel
infect
vari
present
may
subtl
acut
devicerel
infect
suspect
patient
must
thorough
evalu
includ
comprehens
physic
examin
extens
workup
includ
blood
cultur
gram
stain
possibl
cultur
obtain
initi
antimicrobi
therapi
sourc
infect
pneumonia
urinari
tract
catheterrel
infect
must
investig
appropri
addit
diagnost
test
site
specif
exampl
ultrasound
use
evalu
suspect
pump
pocket
infect
transesophag
echocardiogram
use
set
vadrel
endocard
tabl
list
typic
sign
symptom
devicerel
infect
potenti
treatment
option
evid
regard
impact
devicerel
infect
posttranspl
outcom
mix
studi
indic
infect
reduc
overal
surviv
studi
found
seriou
devicerel
infect
persist
posttranspl
period
associ
decreas
earli
longterm
posttranspl
surviv
although
assist
devic
often
associ
infect
benefit
lifesav
therapi
thought
outweigh
infect
risk
major
clinic
implic
preand
postop
nurs
care
list
tabl
infect
transmit
via
allograft
donorderiv
diseas
transmiss
defin
diseas
present
organ
donor
potenti
transmit
least
one
recipi
donorderiv
infecti
diseas
rare
unexpect
transmiss
either
unrecogn
donor
donor
screen
occur
fewer
solid
organ
transplant
procedur
although
rare
infect
caus
signific
morbid
mortal
factor
promot
infect
potenti
organ
donor
includ
use
medic
devic
treatment
patient
certain
unit
high
rate
bacteri
contamin
import
note
treatment
donor
infect
increas
potenti
donor
risk
iatrogen
infect
exampl
via
insert
intravascular
cathet
antimicrobi
therapi
administr
immunomodul
medic
corticosteroid
prolong
hospit
number
reason
infect
potenti
organ
donor
may
difficult
diagnos
donor
may
clinic
manifest
infect
due
insuffici
number
virul
pathogen
hemorrhag
aggress
fluid
resuscit
may
dilut
organ
serolog
infect
marker
undetect
convent
laboratori
test
donor
may
mount
fever
respons
brain
death
caus
loss
temperatur
control
poikilothermia
phenomenon
wherebi
bodi
temperatur
decreas
environ
donor
white
blood
cell
count
may
alreadi
elev
due
trauma
tissu
inflamm
medic
corticosteroid
consequ
diagnosi
infect
may
reli
cultur
urinalysi
report
polymeras
chain
reaction
pcr
nucleic
acid
test
result
characterist
sputum
chang
chest
radiograph
comput
tomographi
ct
scan
potenti
organ
donor
undergo
rigor
infecti
diseas
evalu
organ
procur
transplant
network
optn
polici
mandat
potenti
donor
must
screen
follow
pathogen
human
immunodefici
potenti
heart
donor
screen
toxoplasmosi
mani
donor
also
screen
nosocomi
infect
methicillinresist
staphylcoccu
aureu
vancomycinresist
enterocci
infect
transmit
via
transfus
serolog
test
typic
perform
potenti
donor
receiv
blood
product
addit
famili
member
question
potenti
donor
infect
risk
includ
prior
infect
exposur
histori
immun
travel
endem
area
riski
behavior
intraven
drug
abus
tabl
display
donor
organ
accept
exclus
criteria
base
result
infecti
diseas
screen
accept
organ
donor
known
infect
exposur
hiv
hepat
virus
remain
controversi
given
number
transplant
candid
wait
list
far
exce
number
avail
organ
strategi
expand
donor
pool
includ
accept
donor
certain
infect
higherrisk
serolog
profil
social
histori
suggest
prior
exposur
bloodborn
infect
well
donor
may
risk
transmit
infect
eg
older
donor
donor
long
icu
stay
inform
consent
effect
treatment
bacteri
infect
potenti
organ
donor
result
success
transplant
box
display
import
principl
antibiot
select
administr
potenti
organ
donor
organ
procur
organ
opo
coordin
major
respons
regard
prevent
treatment
infect
report
known
infect
transplant
center
could
potenti
receiv
organ
infect
donor
infect
must
report
transplant
center
list
box
moreov
antimicrobi
agent
given
potenti
donor
must
document
report
transplant
center
receiv
organ
donor
transplant
center
inform
one
organ
recipi
confirm
posit
die
potenti
donorderiv
transmiss
diseas
center
must
notifi
within
one
work
day
opo
procur
organ
opo
must
notifi
optn
report
forward
uno
upload
diseas
transmiss
advisori
committe
dtac
secur
websit
select
bactericid
antibiot
bacteriostat
antibiot
use
medic
directli
target
identifi
bacteria
prevent
remov
harmless
bacteria
promot
select
overgrowth
fungi
resist
organ
abnorm
bacteri
strain
eg
clostridium
difficil
develop
gene
mutat
highli
resist
organ
substitut
direct
antibiot
broadspectrum
agent
sensit
avail
consid
antibiot
specif
effect
anaerob
bacteria
set
facial
injuri
pulmonari
aspir
contamin
wound
injuri
scene
administ
antibiot
intraven
maxim
bioavail
adjust
antibiot
dose
set
renal
failur
hepat
failur
older
donor
age
dtac
data
indic
donor
report
possibl
donorderiv
infecti
diseas
transmiss
recipi
confirm
proven
probabl
possibl
donorderiv
infect
recipi
death
attribut
donorderiv
infect
death
due
hepat
c
tuberculosi
hiv
chaga
diseas
bacteremia
candidemia
strongyloid
lymphocyt
choriomening
viru
three
major
factor
determin
transplant
recipi
risk
infect
includ
patient
epidemiolog
exposur
either
box
infect
must
report
transplant
center
known
condit
may
transmit
donor
organ
must
commun
transplant
center
may
includ
limit
follow
hospit
commun
patient
current
antimicrobi
regimen
patient
net
state
immunosuppress
defin
combin
effect
factor
determin
patient
suscept
infect
net
state
immunosuppress
includ
patient
current
immunosuppress
regimen
number
strength
antireject
agent
well
follow
concurr
factor
infect
immunomodul
viru
eg
cmv
ebv
metabol
autoimmun
disord
eg
diabet
mellitu
neutropenia
lymphopenia
disrupt
mucocutan
barrier
surgic
sequela
eg
fluid
collect
approxim
transplant
recipi
least
one
signific
infect
first
posttranspl
year
three
major
group
posttranspl
pathogen
bacteria
virus
fungi
fig
bacteri
infect
common
follow
viral
fungal
infect
bacteri
infect
frequent
occur
transplant
site
bacteri
pneumonia
common
among
type
solid
organ
transplant
recipi
nosocomi
pathogen
particular
concern
includ
clostridium
difficil
vancomycinresist
enterococcu
methicillinresist
staphylococcu
aureu
extendedspectrum
gramneg
bacilli
common
organspecif
bacteri
infect
associ
risk
factor
list
tabl
posttranspl
viral
infect
caus
two
group
pathogen
herp
virus
cmv
ebv
hsv
varicella
zoster
hepat
virus
viral
infect
particularli
deleteri
direct
indirect
effect
direct
effect
clinic
syndrom
caus
viru
cmv
pneumonia
hepat
indirect
effect
includ
potenti
injuri
allograft
reject
oncogenesi
viru
abil
alter
net
state
immunosuppress
therebi
increas
patient
suscept
opportunist
infect
herp
virus
character
latenc
mean
viru
present
patient
harbor
viral
genom
life
immunosuppress
particularli
augment
immunotherapi
set
reject
trigger
replic
latent
herp
virus
cytomegaloviru
import
pathogen
affect
transplant
recipi
bidirect
relationship
cmv
reject
cmv
trigger
reject
inflammatori
effect
reject
reject
therapi
increas
cmv
viral
replic
allograft
like
affect
cmv
infect
nativ
organ
thu
liver
transplant
recipi
cmv
infect
prone
develop
vanish
bile
duct
syndrom
heart
transplant
recipi
risk
coronari
arteri
vasculopathi
lung
transplant
recipi
risk
bronchiol
obliteran
forth
common
type
cmv
diseas
hepat
pneumon
gastroenter
regard
cmv
serostatu
risk
develop
posttranspl
cmv
infect
highest
cmvseroneg
recipi
receiv
allograft
cmvseroposit
donor
lowest
cmvseroneg
recipi
receiv
allograft
cmvseroneg
donor
recipi
receiv
potent
antireject
therapi
antithymocyt
globulin
also
increas
risk
develop
cmv
infect
concurr
critic
ill
lead
reactiv
latent
cmv
infect
thought
associ
proinflammatori
cytokin
subsequ
downregul
immun
system
agent
use
prevent
treat
cmv
infect
includ
ganciclovir
valganciclovir
acyclovir
cmv
immun
globulin
foscarnet
often
use
treat
ganciclovirresist
organ
cmv
transmit
blood
transfus
cmvseroneg
transplant
candid
recipi
receiv
cmvneg
leukocytepoor
filter
blood
product
given
adult
ebvseroposit
posttranspl
ebv
infect
adult
reactiv
latent
pretranspl
infect
howev
ebvseroneg
recipi
acquir
ebv
infect
blood
transfus
commun
exposur
incid
posttranspl
ebv
infect
highest
multiorgan
intestin
transplant
recipi
follow
decreas
order
kidneypancrea
lung
heart
liver
kidney
recipi
intraven
ganciclovir
use
preemptiv
therapi
patient
high
risk
ebv
infect
exampl
patient
receiv
antilymphocyt
antibodi
therapi
reject
clinic
sequela
ebv
infect
rang
rel
mild
mononucleosislik
syndrom
posttranspl
lymphoprolif
diseas
ptld
treatment
option
mononucleosi
includ
acyclovir
ptld
set
syndrom
rang
benign
selflimit
polyclon
prolifer
b
cell
aggress
malign
monoclon
lymphoma
risk
factor
ptld
includ
pretranspl
ebvneg
serostatu
primari
ebv
infect
high
ebv
viral
load
cmv
serostatu
mismatch
recipi
cmv
neg
donor
cmv
posit
cmv
diseas
potent
reject
treatment
type
allograft
incid
ptld
highest
intestin
transplant
recipi
treatment
option
ptld
rang
antivir
agent
acyclovir
ganciclovir
decreas
immunosuppress
benign
polyclon
form
chemotherapi
radiat
resect
decreas
immunosuppress
malign
monoclon
lymphoma
although
invas
fungal
infect
lowest
incid
infect
associ
highest
morbid
mortal
rate
risk
factor
fungal
infect
includ
use
highdos
corticosteroid
broadspectrum
antibiot
reject
requir
increas
immunosuppress
allograft
dysfunct
simultan
infect
immunomodul
viru
cmv
two
genera
aspergillu
candida
caus
vast
major
posttranspl
fungal
infect
togeth
two
pathogen
account
invas
fungal
infect
infect
typic
present
first
month
posttranspl
occur
time
common
fungal
infect
involv
respiratori
tract
invas
aspergillosi
may
affect
approxim
solid
organ
transplant
recipi
portal
entri
includ
gastrointestin
tract
skin
risk
dissemin
candidiasi
highest
neutropen
patient
central
venou
cathet
receiv
broadspectrum
antibiot
prolong
icu
stay
liver
transplant
recipi
highest
risk
invas
candidiasi
follow
decreas
order
pancrea
lung
heartlung
kidney
heart
transplant
recipi
pediatr
transplant
recipi
often
higher
risk
posttranspl
infect
number
reason
includ
lack
immun
common
pathogen
cmv
ebv
incomplet
immun
increas
technic
difficulti
prolong
transplant
oper
time
due
pretranspl
palli
surgeri
inabl
close
abdomen
chest
due
placement
larg
allograft
small
child
social
behavior
children
dens
popul
day
care
school
set
acut
mediastin
develop
implant
mechan
circulatori
assist
devic
heart
lung
heartlung
transplant
risk
posttranspl
mediastin
higher
patient
mechan
circulatori
assist
devic
total
artifici
heart
bridg
transplant
preoper
intraop
postop
risk
factor
mediastin
exampl
preoper
risk
factor
includ
diabet
mellitu
prior
sternotomi
renal
failur
requir
dialysi
prolong
hospit
transplant
surgeri
obes
risk
develop
mediastin
doubl
patient
bodi
mass
index
greater
intraop
risk
factor
includ
blood
transfus
prolong
cardiopulmonari
bypass
aortic
crossclamp
oper
time
exampl
postop
risk
factor
includ
surgic
reexplor
prolong
icu
stay
prolong
mechan
ventil
hour
tracheostomi
cardiopulmonari
resuscit
poor
periop
postop
glucos
control
low
posttranspl
cardiac
output
major
etiolog
pathogen
associ
mediastin
includ
decreas
order
gramposit
cocci
staphylococcu
aureu
staphylococcu
epidermidi
enterococcu
spp
streptococcu
spp
gramneg
bacilli
escherichia
coli
enterobact
spp
klebsiella
spp
proteu
spp
enterobacteriacea
pseudomona
spp
fungi
candida
albican
initi
clinic
manifest
mediastin
may
subtl
mild
chest
pain
edema
erythema
along
sternal
incis
common
present
symptom
fever
may
associ
local
infect
erythema
cellul
purul
drainag
pleuriticlik
pain
sternal
instabl
diagnost
studi
includ
ct
scan
cultur
laboratori
test
laboratori
find
includ
elev
white
blood
cell
count
c
reactiv
protein
procalcitonin
latter
test
particularli
use
distinguish
reject
infect
mediastin
diagnos
treatment
initi
promptli
therapeut
option
includ
surgic
wound
irrig
tailor
parenter
antimicrobi
agent
nutrit
support
transplant
recipi
central
nervou
system
cn
infect
among
deleteri
difficult
diagnos
treat
diagnosi
often
challeng
present
symptom
mental
statu
chang
seizur
focal
neurolog
deficit
headach
may
blunt
immunosuppress
therapi
moreov
neurotox
effect
antibiot
antivir
agent
immunosuppress
may
make
diagnosi
even
complic
first
step
diagnos
suspect
cn
infect
neuroimag
studi
establish
presenc
locat
potenti
etiolog
characterist
lesion
magnet
reson
imag
studi
brain
spinal
cord
typic
prefer
ct
scan
neuroimag
studi
use
determin
infect
focal
nonfoc
involv
mening
diagnost
test
includ
cerebrospin
fluid
analys
electroencephalogram
viral
polymeras
chain
reaction
test
cultur
serolog
test
brain
biopsi
rare
done
except
set
posttranspl
lymphoprolif
diseas
brain
abscess
posttranspl
interv
patientspecif
risk
factor
time
evolut
clinic
manifest
also
help
inform
diagnosi
cn
infect
may
caus
fungi
virus
bacteria
fungal
infect
carri
highest
mortal
higherof
pathogen
brain
abscess
associ
aspergillu
abscess
tend
occur
earli
posttranspl
period
particularli
recipi
multipl
risk
factor
infect
surgic
reexplor
depend
mechan
ventil
dialysi
retransplant
unlik
mening
immunocompet
patient
posttranspl
mening
typic
caus
fungi
set
patient
often
develop
system
infect
subsequ
spread
cn
viral
cn
infect
may
associ
reactiv
latent
viru
jc
virusinduc
progress
multifoc
leukoencephalopathi
may
caus
new
exposur
pathogen
west
nile
viru
pathogen
commonli
associ
posttranspl
enceph
includ
herp
simplex
viru
varicella
zoster
viru
ebv
cmv
bacteri
cn
infect
frequent
caus
listeria
nocardia
rather
common
bacteri
pathogen
due
sever
cn
infect
transplant
recipi
infecti
diseas
consult
coupl
prompt
diagnosi
treatment
imper
empir
broadspectrum
antimicrobi
agent
typic
administ
caus
organ
identifi
immunosuppress
agent
blunt
inflammatori
respons
infect
howev
case
transplant
recipi
infect
increas
temperatur
infect
howev
tend
occur
absenc
fever
includ
pneumocysti
pneumonia
focal
fungal
lung
infect
cryptococc
mening
patient
persist
fever
greater
acut
pulmonari
infiltr
typic
hospit
infect
workup
fever
unknown
origin
commonli
associ
cmv
ebv
viral
syndrom
import
note
fever
transplant
recipi
may
also
caus
drug
reaction
particularli
antilymphocyt
therapi
pulmonari
emboli
deep
vein
thrombosi
reject
rejectioninduc
fever
typic
occur
lung
transplant
recipi
occur
less
commonli
kidney
liver
transplant
recipi
rare
heart
recipi
given
human
be
frequent
sourc
infect
patient
environ
essenti
nurs
prevent
nosocomi
transmiss
respiratori
virus
transmiss
organ
contamin
hand
inanim
object
addit
import
critic
care
nurs
follow
standard
precaut
use
asept
techniqu
vascular
urinari
cathet
ensur
ventil
circuit
cathet
dress
chang
per
protocol
inspect
percutan
cathet
site
sign
infect
maintain
close
system
urinari
suction
cathet
keep
head
bed
elev
decreas
risk
aspir
restrict
access
patient
visitor
staff
cold
contagi
ill
avoid
transport
transplant
recipi
area
hospit
construct
promptli
recogn
report
clinic
manifest
infect
obtain
report
diagnost
test
result
time
manner
administ
document
antimicrobi
agent
time
manner
assess
report
vaccin
statu
transplant
candid
recipi
know
cmv
ebv
pertin
serostatus
donor
recipi
infect
import
issu
critic
care
nurs
care
patient
throughout
phase
transplant
continuum
potenti
organ
donor
transplant
candid
transplant
recipi
articl
review
salient
issu
rel
infect
patient
popul
includ
patient
vad
highlight
key
point
pertain
bacteri
viral
fungal
infect
